Strattera Linked to Liver Damage

Strattera, the first non-stimulant ADHD medication, has been linked to liver damage, the FDA warns. The FDA is advising health care professionals about a new warning for Strattera. The labeling warns that severe liver damage may progress to liver failure resulting in death or the need for a liver transplant in a small percentage of patients taking Strattera. The labeling also notes that the number of actual cases of severe liver damage is unknown because of under-reporting of post-marketing adverse events. Click [here] to view the full version of this article.